Risk-reducing bilateral salpingo-oophorectomy (RRBSO) is the gold standard for the prevention of ovarian cancer with an 80–96% risk reduction in patients with BRCA1/2 GPVs [38]. The gene discussed is BRCA1; the disease is ovarian carcinoma.